Increased NF-κB activity in fibroblasts lacking the vitamin D receptor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 2, 2006, Pages

  Sun, Jun ^a   Kong, Juan ^a   Duan, Yingli ^a   Szeto, Frances L ^a   Liao, Anne ^a   Madara, James L ^a   Yan, Chun Li ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Inflammation; Mouse embryonic fibroblasts; Nuclear factor B

Indexed keywords

I KAPPA B; I KAPPA B BETA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; P65 ONCOFETAL MRNA TRANSPORT PROTEIN, RAT; TUMOR PROTEIN; VITAMIN D;

ANIMAL CELL; ARTICLE; DNA BINDING; FIBROBLAST; INFLAMMATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SALMONELLOSIS; ANIMAL; CELL CULTURE; METABOLISM;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; I-KAPPA B PROTEINS; MICE; NEOPLASM PROTEINS; NF-KAPPA B; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 33745839652     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00590.2005     Document Type: Article

References (41)

1. Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, and Oehler L. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28: 575-583, 2000.
2. Bhalla AK, Amento EP, Serog B, and Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133: 1748-1754, 1984.
3. Bonizzi G and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288, 2004.
4. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, and O'Garra A. 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-4980, 2001.
5. Cantorna MT, Hayes CE, and DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93: 7861-7864, 1996.
6. Church GM and Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984.
7. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, and Panina-Bordignon P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101: 252-262, 1998.
8. Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, and Griffin MD. Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem 278: 49378-49385, 2003.
9. Etten EV and Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D(3): basic concepts. J Steroid Biochem Mol Biol 97: 93-101, 2005.
10. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, and Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386-2392, 2003.
11. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, and Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 173: 2280-2287, 2004.
12. Gurlek A, Pittelkow MR, and Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23: 763-786, 2002.
13. Harant H, Wolff B, and Lindley IJ. 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett 436: 329-334, 1998.
14. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, and Jurutka PW. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998.
15. Jian Y, Yan J, Wang H, Chen C, Sun M, Jiang J, Lu J, Yang Y, and Gu J. Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity. Biochem Biophys Res Commun 335: 739-748, 2005.
16. Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, and Stymne B. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 205: 389-393, 2002.
17. Kong J, Grando SA, and Li YC. Regulation of interleukin-1 family cytokines interleukin-1alpha, interleukin-1 receptor antagonist and interleukin-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes. J Immunol. 176: 3780-3787, 2006.
18. Lahfa M, Mrowietz U, Koenig M, and Simon JC. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. Eur J Dermatol 13: 261-265, 2003.
19. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49: 26-31, 1992.
20. Li YC, Bolt MJG, Cao LP, and Sitrin MD. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab 281: E558-E564, 2001.
21. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, and Demay MB. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94: 9831-9835, 1997.
22. Lim WC, Hanauer SB, and Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2: 308-315, 2005.
23. Lu X, Farmer P, Rubin J, and Nanes MS. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem 92: 833-848, 2004.
24. Mahon BD, Wittke A, Weaver V, and Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89: 922-932, 2003.
25. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, and Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 89-90: 449-452, 2004.
26. Mathieu C, Waer M, Casteels K, Laureys J, and Bouillon R. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136: 866-872, 1995.
27. Mathieu C, Waer M, Laureys J, Rutgeerts O, and Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37: 552-558, 1994.
28. Miller SI and Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 172: 2485-2490, 1990.
29. Nagpal S, Na S, and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687, 2005.
30. Nakanishi C and Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5: 297-309, 2005.
31. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, and Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563, 2000.
32. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, and Munoz A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387, 2001.
33. Penna G and Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411, 2000.
34. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, and Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443-4451, 2000.
35. Rigby WF, Denome S, and Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79: 1659-1664, 1987.
36. Rigby WF, Stacy T, and Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74: 1451-1455, 1984.
37. Riis JL, Johansen C, Gesser B, Moller K, Larsen CG, Kragballe K, and Iversen L. 1 Alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Arch Dermatol Res 296: 195-202, 2004.
38. Sun J, Hobert ME, Rao AS, Neish AS, and Madara JL. Bacterial activation of β-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol 287: G220-G227, 2004.
39. Todaro GJ and Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299-313, 1963.
40. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, and Kato S. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283: 1317-1321, 1999.
41. Yu XP, Bellido T, and Manolagas SC. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 92: 10990-10994, 1995. [Corrigenda. Proc Natl Acad Sci USA 93: Jan 1996, p. 524.]